Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Dermatology | Family Medicine
Search Medical Condition
Acne Clinical Trials
A listing of Acne medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (152) clinical trials
Acne, psoriasis, atopic dermatitis
A 52-week, multicenter, randomized, double-blind study of secukinumab (300mg) to demonstrate efficacy as assessed by psoriasis area and severity index and investigator's global assessment after 12 weeks of treatment, compared to ustekinumab, and to assess long-term safety, tolerability, and efficacy in subjects with moderate to severe plaque psoriasis.
Hidradenitis Suppurativa Research Study
Looking for patients at least 18 years of age and diagnosed with HS.
Multicenter, randomized, double-blind, placebo-controlled, parallel group study, with two secukinumab dose regimens in approximately 471 patients with moderate to severe HS
The purpose of this study is to demonstrate superiority of secukinumab at Week 16, based on Hidradenitis Suppurativa Clinical Response (HiSCR) rates versus placebo, along with the maintenance of efficacy of secukinumab at Week 52 in subjects with moderate to severe HS. Moreover, this study will also assess the safety ...
Hidradenitis Suppurativa
The objective of this study is to evaluate the effectiveness of the study medication in those with moderate to severe hidradenitis suppurativa. This study is a 44-week study with up to 13 office visits.
Acne Research Study
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
Physical exam and assessments of study condition to be provided at no cost by an experienced provider. No insurance necessary. Compensation will be provided at the end of study participation.
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
The 12-week, phase 2 study is intended to evaluate the safety and efficacy of IDP-126 Gel, a novel fixed-dose combination of clindamycin phosphate, benzoyl peroxide and adapalene relative to placebo and dual component combinations for the treatment of acne vulgaris in subjects 9 years of age and older. All subjects will ...
A Phase 2, Open-Label, Single-Arm Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Primary end point: To evaluate the safety and tolerability of INCB054707. Secondary end point: To evaluate the systemic exposure and evaluate the efficacy of INCB054707. Overall design: This is a Phase 2, multicenter, open-label, single-arm study to assess the safety of 15 mg QD INCB054707 over 8 weeks in men and women aged 18 ...
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
The main purpose of this study is to evaluate the safety, efficacy, and tolerability of a once-daily topical application of IDP-126 Gel in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-126 Gel is a fixed dose combination ...
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-123 Lotion and IDP-123 Vehicle Lotion in the Treatment of Acne Vulgaris
The main purpose of this study is to compare the safety, efficacy, and tolerability of a once-daily topical application of IDP-123 Lotion compared to the IDP-123 Vehicle Lotion in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-123 ...
